The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period. The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players is certain factors driving the growth of the depression treatment industry. In February 2021, Zydus Cadila has received US FDA approval for Nortriptyline...